With a robust background in strategic investments and operational leadership, Samuel J. Conte II has positioned himself as a formidable player in the private equity landscape. His expertise extends across various sectors, including technology and healthcare, where he leverages his deep understanding of market dynamics to drive growth initiatives. Serving as both an investor-operator and advisor, he combines entrepreneurial insight with rigorous analysis to uncover value-driven opportunities. Throughout his career, Samuel has cultivated strong relationships within investment networks, allowing him to facilitate collaborative ventures that align stakeholder interests while generating significant returns.
With a robust background in strategic investments and operational leadership, Samuel J. Conte II has positioned himself as a formidable player in the private equity landscape. His expertise extends across various sectors, including technology and healthcare, where he leverages his deep understanding of market dynamics to drive growth initiatives. Serving as both an investor-operator and advisor, he combines entrepreneurial insight with rigorous analysis to uncover value-driven opportunities. Throughout his career, Samuel has cultivated strong relationships within investment networks, allowing him to facilitate collaborative ventures that align stakeholder interests while generating significant returns.
Samuel J. Conte II identifies opportunities by leveraging his entrepreneurial acumen and extensive network within the private equity space. His strategic mindset is shaped by hands-on experience in operational leadership, which informs his decisions across diverse sectors, particularly technology and healthcare. Growth initiatives are prioritized through a careful analysis of market trends and competitive dynamics, allowing him to position investments for optimal impact. With a focus on collaborative ventures, he emphasizes creating synergies among stakeholders to unlock long-term value while fostering innovation-driven strategies that can navigate evolving landscapes.
Samuel J. Conte II identifies opportunities by leveraging his entrepreneurial acumen and extensive network within the private equity space. His strategic mindset is shaped by hands-on experience in operational leadership, which informs his decisions across diverse sectors, particularly technology and healthcare. Growth initiatives are prioritized through a careful analysis of market trends and competitive dynamics, allowing him to position investments for optimal impact. With a focus on collaborative ventures, he emphasizes creating synergies among stakeholders to unlock long-term value while fostering innovation-driven strategies that can navigate evolving landscapes.
| Trades 1121 | Longs Won 794/1121 70% | Profit Factor 13.6 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $374,246.24 |
| Average Win $121,796.4 | Best Trade (Sep 09) $7.26M | Sharpe Ratio -10.5 |
| Average Loss -$21,751.61 | Worst Trade (Aug 03) -$1.06M | Z-Score 14.99 (100%) |
| Commissions $0 | Avg. Trade Length 1y 8m 1w 1d | Expectancy $79,922.9 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 11,905 | 10,714 | 9,524 | 8,333 | 7,143 | 5,952 | 4,762 | 3,571 | 2,381 | 1,190 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 21,573 | $4.43M | $7.21M | - | $2.78M | 62.7% | +0.539% |
ABBV AbbVie Inc. | 9,350 | $1.51M | $2.45M | - | $934,532.5 | 61.85% | +1.727% |
ALLE Allegion plc | 1,519 | $218,918 | $235,581.71 | - | $16,663.71 | 7.61% | +1.135% |
AMGN Amgen Inc. | 6,297 | $1.76M | $2.4M | - | $641,553.49 | 36.41% | +1.163% |
AMZN Amazon.com Inc | 9,300 | $2.04M | $2.36M | - | $317,474.95 | 15.55% | -1.223% |
AVGO Broadcom Inc. | 1,090 | $300,458 | $375,690.3 | - | $75,232.3 | 25.04% | -4.785% |
AZN AstraZeneca PLC American Depositary Shares | 1,400 | $276,108 | $228,949 | - | -$47,159 | -17.08% | +2.101% |
BA Boeing Company | 6,465 | $1.36M | $1.36M | - | -$5,234.67 | -0.38% | -0.209% |
BAC Bank of America Corporation | 75,615 | $3.6M | $4.49M | - | $892,259.48 | 24.81% | -5.304% |
BIIB Biogen Inc. | 3,180 | $831,465.3 | $693,876 | - | -$137,589.3 | -16.55% | +0.484% |
BKR Baker Hughes Company | 28,550 | $1.13M | $1.62M | - | $491,230.82 | 43.58% | -4.013% |
BRK-B Berkshire Hathaway Inc. | 5,192 | $2.52M | $2.68M | - | $154,837.1 | 6.14% | +1.045% |
BSV Vanguard Short-Term Bond ETF | 27,742 | $2.09M | $2.13M | - | $35,131.93 | 1.68% | -0.007% |
C Citigroup Inc. | 51,475 | $2.67M | $7.06M | - | $4.39M | 164.39% | -1.243% |
CARR Carrier Global Corporation | 22,735 | $1.39M | $1.3M | - | -$87,007.11 | -6.26% | -0.296% |
CAT Caterpillar Inc. | 6,146 | $1.61M | $4.82M | - | $3.22M | 200.29% | -4.152% |
CL Colgate-Palmolive Company | 13,203 | $1.05M | $1.16M | - | $115,316.78 | 10.99% | +1.601% |
CMI Cummins Inc. | 4,855 | $1.26M | $2.63M | - | $1.37M | 109.18% | -2.876% |
COP ConocoPhillips | 43,305 | $5.42M | $5.91M | - | $485,713.59 | 8.96% | -0.655% |
COST Costco Wholesale Corporation | 2,610 | $1.29M | $2.4M | - | $1.11M | 85.56% | +1.617% |